Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018–20

[1]  W. Moss,et al.  Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018–2020 , 2022, The Lancet. Global health.

[2]  Carl D Britto,et al.  COVID-19-related disruptions to routine vaccination services in India: a survey of paediatric providers , 2021, BMJ Paediatrics Open.

[3]  D. Durrheim,et al.  A dangerous measles future looms beyond the COVID-19 pandemic , 2021, Nature Medicine.

[4]  F. Cutts,et al.  Challenges in measuring supplemental immunization activity coverage among measles zero-dose children. , 2021, Vaccine.

[5]  A. Tatem,et al.  Vaccination strategies for measles control and elimination: time to strengthen local initiatives , 2021, BMC Medicine.

[6]  Kidane Tadesse Gebremariam,et al.  Mapping routine measles vaccination in low- and middle-income countries , 2020, Nature.

[7]  J. Lepkowski,et al.  Vaccination Inequality in India, 2002-2013. , 2020, American journal of preventive medicine.

[8]  M. A. Nicolaie,et al.  Dynamics of the Antibody Response After a Third Dose of Measles-Mumps-Rubella Vaccine Indicate a Slower Decline Compared With a Second Dose , 2020, Open forum infectious diseases.

[9]  John Ndegwa Wagai,et al.  Implementing WHO guidance on conducting and analysing vaccination coverage cluster surveys: Two examples from Nigeria , 2020, PloS one.

[10]  R. Limaye,et al.  Characterizing mothers and children at risk of being under-immunized in India: A latent class analysis approach , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[11]  R. K. Sachdeva,et al.  Epidemiology of Congenital Rubella Syndrome (CRS) in India, 2016-18, based on data from sentinel surveillance , 2020, PLoS neglected tropical diseases.

[12]  B. Hagedorn,et al.  The cost saving opportunity of introducing a card review into measles-containing vaccination campaigns. , 2019, Vaccine.

[13]  Q. Hasan,et al.  Decreasing measles burden by optimizing campaign timing , 2019, Proceedings of the National Academy of Sciences.

[14]  M. Ferrari,et al.  Correlation between measles vaccine doses: implications for the maintenance of elimination , 2018, Epidemiology and Infection.

[15]  M. Jit,et al.  Impact of measles supplementary immunization activities on reaching children missed by routine programs. , 2018, Vaccine.

[16]  C. Mathers,et al.  Changes in cause-specific neonatal and 1–59-month child mortality in India from 2000 to 2015: a nationally representative survey , 2017, The Lancet.

[17]  C. Jackson,et al.  Using Seroprevalence and Immunisation Coverage Data to Estimate the Global Burden of Congenital Rubella Syndrome, 1996-2010: A Systematic Review , 2016, PloS one.

[18]  K. Wannemuehler,et al.  Cluster Survey Evaluation of a Measles Vaccination Campaign in Jharkhand, India, 2012 , 2015, PloS one.

[19]  M. Ferrari,et al.  Reaching Hard-to-Reach Individuals: Nonselective Versus Targeted Outbreak Response Vaccination for Measles , 2013, American journal of epidemiology.

[20]  Dale A. Rhoda,et al.  Measuring Coverage in MNCH: Design, Implementation, and Interpretation Challenges Associated with Tracking Vaccination Coverage Using Household Surveys , 2013, PLoS medicine.

[21]  Elizabeth T Luman,et al.  Validity of vaccination cards and parental recall to estimate vaccination coverage: a systematic review of the literature. , 2013, Vaccine.

[22]  D. Henderson,et al.  Measles and rubella eradication in the Americas. , 2011, Vaccine.

[23]  P. Khanna,et al.  Introduction of a second dose of measles in National immunization program in India: A major step towards eradication , 2011, Human vaccines.

[24]  C. Sudfeld,et al.  Effectiveness of measles vaccination and vitamin A treatment , 2010, International journal of epidemiology.

[25]  E. Vynnycky,et al.  The predicted impact of private sector MMR vaccination on the burden of Congenital Rubella Syndrome. , 2003, Vaccine.

[26]  N. Gay,et al.  Measles elimination in the Americas. , 1996, JAMA.

[27]  D A Henderson,et al.  Measles elimination in the Americas. Evolving strategies. , 1996, JAMA.

[28]  A. Hinman,et al.  Worldwide measles prevention. , 1994, Israel journal of medical sciences.

[29]  E. Dansereau,et al.  A systematic review of the agreement of recall, home-based records, facility records, BCG scar, and serology for ascertaining vaccination status in low and middle-income countries , 2019, Gates open research.

[30]  J. Valadez,et al.  Maternal recall error of child vaccination status in a developing nation. , 1992, American journal of public health.

[31]  F. Cutts,et al.  The epidemiology of measles. , 1992, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.